Zions Bancorporation’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $6.03K | Buy |
40
+9
| +29% | +$1.4K | ﹤0.01% | 679 |
|
|
2024
Q3 | $4.81K | Hold |
31
| – | – | ﹤0.01% | 717 |
|
|
2024
Q2 | $4.24K | Sell |
31
-16
| -34% | -$2.19K | ﹤0.01% | 772 |
|
|
2024
Q1 | $6.26K | Hold |
47
| – | – | ﹤0.01% | 727 |
|
|
2023
Q4 | $6.48K | Sell |
47
-35
| -43% | -$4.6K | ﹤0.01% | 715 |
|
|
2023
Q3 | $9.99K | Sell |
82
-7
| -8% | -$933 | ﹤0.01% | 633 |
|
|
2023
Q2 | $12.5K | Sell |
89
-1
| -1% | -$138 | ﹤0.01% | 601 |
|
|
2023
Q1 | $12.7K | Buy |
90
+8
| +10% | +$1.15K | ﹤0.01% | 601 |
|
|
2022
Q4 | $12.8K | Sell |
82
-2
| -2% | -$287 | ﹤0.01% | 650 |
|
|
2022
Q3 | $10K | Sell |
84
-13
| -13% | -$1.71K | ﹤0.01% | 662 |
|
|
2022
Q2 | $13K | Buy |
97
+27
| +39% | +$3.68K | ﹤0.01% | 683 |
|
|
2022
Q1 | $10K | Sell |
70
-25
| -26% | -$3.48K | ﹤0.01% | 815 |
|
|
2021
Q4 | $16K | Buy |
95
+38
| +67% | +$5.78K | ﹤0.01% | 652 |
|
|
2021
Q3 | $8K | Buy |
57
+7
| +14% | +$1.02K | ﹤0.01% | 762 |
|
|
2021
Q2 | $7K | Buy |
50
+4
| +9% | +$524 | ﹤0.01% | 779 |
|
|
2021
Q1 | $6K | Buy |
46
+12
| +35% | +$1.48K | ﹤0.01% | 782 |
|
|
2020
Q4 | $4K | Sell |
34
-5
| -13% | -$610 | ﹤0.01% | 807 |
|
|
2020
Q3 | $4K | Buy |
39
+6
| +18% | +$709 | ﹤0.01% | 841 |
|
|
2020
Q2 | $4K | Sell |
33
-24
| -42% | -$2.55K | ﹤0.01% | 768 |
|
|
2020
Q1 | $5K | Sell |
57
-488
| -90% | -$50.5K | ﹤0.01% | 693 |
|
|
2019
Q4 | $58K | Buy |
545
+359
| +193% | +$37.4K | 0.01% | 389 |
|
|
2019
Q3 | $20K | Hold |
186
| – | – | ﹤0.01% | 589 |
|
|
2019
Q2 | $19K | Buy |
186
+14
| +8% | +$1.34K | ﹤0.01% | 553 |
|
|
2019
Q1 | $15K | Buy |
172
+126
| +274% | +$10.9K | ﹤0.01% | 617 |
|
|
2018
Q4 | $4K | Sell |
46
-129
| -74% | -$12.1K | ﹤0.01% | 389 |
|
|
2018
Q3 | $19K | Hold |
175
| – | – | ﹤0.01% | 492 |
|
|
2018
Q2 | $19K | Buy |
+175
| New | +$18.2K | 0.01% | 280 |
|
|
2017
Q4 | – | Sell |
-184
| Closed | -$17K | – | 705 |
|
|
2017
Q3 | $17K | Buy |
184
+160
| +667% | +$17K | ﹤0.01% | 755 |
|
|
2017
Q2 | $3K | Sell |
24
-19
| -44% | -$2.01K | ﹤0.01% | 516 |
|
|
2017
Q1 | $4K | Buy |
43
+24
| +126% | +$2.29K | ﹤0.01% | 523 |
|
|
2016
Q4 | $2K | Hold |
19
| – | – | ﹤0.01% | 746 |
|
|
2016
Q3 | $2K | Hold |
19
| – | – | ﹤0.01% | 711 |
|
|
2016
Q2 | $2K | Hold |
19
| – | – | ﹤0.01% | 703 |
|
|
2016
Q1 | $1K | Hold |
19
| – | – | ﹤0.01% | 818 |
|
|
2015
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 779 |
|
|
2015
Q3 | $1K | Buy |
+19
| New | +$1.33K | ﹤0.01% | 793 |
|
|
2015
Q2 | – | Sell |
-40
| Closed | -$3K | – | 380 |
|
|
2015
Q1 | $3K | Buy |
+40
| New | +$2.87K | ﹤0.01% | 719 |
|
Other funds holding DGX
DSA
Zions Bancorporation's DGX Position: Q4 2024 in Review
Zions Bancorporation increased its Quest Diagnostics (DGX) stake by 29% in Q4 2024, buying an estimated $1.4K and bringing the position to 40 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #679.
Zions Bancorporation first reported a position in DGX in Q1 2015 and has held it in 37 quarters since. The position peaked at $58K in Q4 2019. 896 funds tracked by Wall St. Rank hold DGX as of Q4 2024.
- Zions Bancorporation held 40 shares of Quest Diagnostics worth $6.03K as of Q4 2024.
- Zions Bancorporation bought 9 Quest Diagnostics shares in Q4 2024, an estimated $1.4K.
- Quest Diagnostics made up ﹤0.01% of Zions Bancorporation's portfolio in Q4 2024, its #679 holding.
- Zions Bancorporation first reported a position in Quest Diagnostics in Q1 2015 and has held it in 37 quarters since.
- Zions Bancorporation's Quest Diagnostics position peaked at $58K in Q4 2019.
- 896 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.